当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析 - 现金流量表

国药一致

(000028)

  

流通市值:121.52亿  总市值:141.48亿
流通股本:4.78亿   总股本:5.57亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金55,095,736,377.336,305,841,030.9515,787,668,453.6479,383,613,590.36
  收到的税费返还3,635,067.143,574,848.22447,835.047,735,047.12
  收到其他与经营活动有关的现金541,664,883.96432,329,310.11436,687,408.251,017,351,924.13
  经营活动现金流入小计55,641,036,328.436,741,745,189.2816,224,803,696.9380,408,700,561.61
  购买商品、接受劳务支付的现金50,834,224,228.6233,253,061,022.8116,306,738,764.8369,771,420,769.44
  支付给职工以及为职工支付的现金2,414,309,062.071,722,958,625.3937,887,158.613,488,147,660.18
  支付的各项税费1,257,341,788.57858,556,250396,466,631.281,779,197,158.42
  支付其他与经营活动有关的现金1,598,237,669.55892,102,600.89400,981,140.052,098,466,676.54
  经营活动现金流出小计56,104,112,748.8136,726,678,49918,042,073,694.7777,137,232,264.58
  经营活动产生的现金流量净额-463,076,420.4115,066,690.28-1,817,269,997.843,271,468,297.03
二、投资活动产生的现金流量:
  收回投资收到的现金3,912,324.063,912,324.063,912,324.0620,614,176.96
  取得投资收益收到的现金98,930,230.7346,021,170.13274,170.13187,595,964.62
  处置固定资产、无形资产和其他长期资产收回的现金净额1,256,021.6797,830.82175,990.41,197,954.34
  收到的其他与投资活动有关的现金---8,034,149.27
  投资活动现金流入小计104,098,576.3950,731,325.014,362,484.59217,442,245.19
  购建固定资产、无形资产和其他长期资产支付的现金173,166,529.73114,399,722.0764,305,655.73282,695,594.62
  投资支付的现金480,000400,000-14,032,260
  取得子公司及其他营业单位支付的现金7,415,683.18--71,400,000
  支付其他与投资活动有关的现金114,345.33---
  投资活动现金流出小计181,176,558.24114,799,722.0764,305,655.73368,127,854.62
  投资活动产生的现金流量净额-77,077,981.85-64,068,397.06-59,943,171.14-150,685,609.43
三、筹资活动产生的现金流量:
  吸收投资收到的现金6,900,000--2,000,000
  其中:子公司吸收少数股东投资收到的现金6,900,000--2,000,000
  取得借款收到的现金1,496,109,982.711,019,035,644.36637,467,206.841,560,135,333.4
  收到其他与筹资活动有关的现金63,280,877.4358,433,568.9723,717,178.29262,104,595.31
  筹资活动现金流入小计1,566,290,860.141,077,469,213.33661,184,385.131,824,239,928.71
  偿还债务支付的现金1,186,666,726.73858,727,794.62274,275,700.351,575,149,262.99
  分配股利、利润或偿付利息支付的现金381,174,391.92317,389,250.3248,258,090.01671,211,382.94
  其中:子公司支付给少数股东的股利、利润39,623,253.9618,307,308.841,133,521.2367,445,717.47
  支付其他与筹资活动有关的现金1,312,302,642.93564,191,865.61246,589,548.151,409,115,430.8
  筹资活动现金流出小计2,880,143,761.581,740,308,910.55569,123,338.513,655,476,076.73
  筹资活动产生的现金流量净额-1,313,852,901.44-662,839,697.2292,061,046.62-1,831,236,148.02
四、汇率变动对现金及现金等价物的影响-73,715.79-74,564.57873.42-1,196,465.06
五、现金及现金等价物净增加额-1,854,081,019.49-711,915,968.57-1,785,151,248.941,288,350,074.52
  加:期初现金及现金等价物余额7,123,644,530.877,123,644,530.877,123,644,530.875,835,294,456.35
  期末现金及现金等价物余额5,269,563,511.386,411,728,562.35,338,493,281.937,123,644,530.87
补充资料:
  净利润-712,593,802.45-237,003,526.49
  资产减值准备-93,738,902.35-994,531,638.52
  固定资产和投资性房地产折旧-91,398,240.73-1,478,078,694
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-91,398,240.73-1,478,078,694
  无形资产摊销-31,743,440.14-67,270,966.46
  长期待摊费用摊销-99,503,790.44-198,395,234.03
  处置固定资产、无形资产和其他长期资产的损失--4,116,939.6--11,871,648.1
  固定资产报废损失-1,230,693.2-1,916,115.87
  公允价值变动损失---20,675,083.9
  财务费用-91,098,772.3-258,301,906.01
  投资损失--180,244,712.09--379,677,806.48
  递延所得税--36,959,569.44--55,228,181.02
  其中:递延所得税资产减少--29,861,240.48--23,679,443.18
    递延所得税负债增加--7,098,328.96--31,548,737.84
  存货的减少--671,057,153.44-559,597,921.71
  经营性应收项目的减少--3,374,451,275.03--965,326,601.2
  经营性应付项目的增加-2,665,316,045.23-463,053,069.7
  其他--121,019,787.21-305,422,559.01
  不涉及现金收支的投资和筹资活动金额其他项目-237,075,805.46-1,086,088,548.98
  现金的期末余额-6,411,728,562.3-7,123,644,530.87
  减:现金的期初余额-7,123,644,530.87-5,835,294,456.35
  现金及现金等价物的净增加额--711,915,968.57-1,288,350,074.52
公告日期2025-10-312025-08-302025-04-252025-04-08
审计意见(境内)标准无保留意见
TOP↑